Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females

• Main Authors: Li-Wei Shi (Author), Juan Li (Author), Bang-Wei Yu (Author), Li-Rong Huang (Author), Ke Li (Author), Min Ji (Author), Ling-Yun Zhou (Author), Lin Yuan (Author), Shu-Yuan Yang (Author), Jing-Jing Chen (Author), Ling Wang (Author), Zhi-Wei Jiang (Author), Rong-Cheng Li (Author), Yan-Ping Li (Author), Jie-Lai Xia (Author), Zhao-Jun Mo (Author), Chang-Gui Li (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

As global supply is still inadequate to address the worldwide requirements for HPV vaccines, we assessed the safety and immunogenicity of a new bivalent HPV16/18 vaccine. In this randomized, double-blind, placebo-controlled, phase 2 trial, healthy 9-45-year-old Chinese females in three age cohorts (...